Millstone Evans Group, LLC Merck & Co., Inc. Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q4 2024
A detailed history of Millstone Evans Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Millstone Evans Group, LLC holds 13,181 shares of MRK stock, worth $1.14 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
13,181Holding current value
$1.14 Million% of portfolio
0.89%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,873Shares Held
1.89BCall Options Held
16.1MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA251MShares$21.7 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.3 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.55 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.11 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $219B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...